Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/25/2008US20080318979 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
12/25/2008US20080318978 Hyperaldosteronism; 4-(5,6,7,8-Tetrahydroimidazo[1,5-a]phyridin-5-yl)cyclohexanecarbonitrile; 1-[3-(5,6,7,8-Tetrahydroimidazo[1,5-a]pyridin-8-yl)pyrrolidin-1-yl]ethanone
12/25/2008US20080318977 Condensed Pyridines as Kinase Inhibitors
12/25/2008US20080318976 Alpha-Hydroxy Amides as Bradykinin Antagonists or Inverse Agonists
12/25/2008US20080318975 Prevent transplant rejection
12/25/2008US20080318974 Such as 1-[2-(piperidin-3-ylmethoxy)-5-trifluoromethyl-phenyl]-3-(5-trifluoromethyl-pyrazin-2-yl)-urea hydrochloride salt; checkpoint kinase (Chk1) inhibitors; cancer; diseases characterized by defects in DNA replication, chromosome segregation and/or cell division
12/25/2008US20080318973 Urotensin II receptor antagonists
12/25/2008US20080318972 5-ht1a receptor subtype agonist
12/25/2008US20080318971 using bosutinib
12/25/2008US20080318970 Treatment of Infectious Diseases
12/25/2008US20080318969 Anti-anginal compounds
12/25/2008US20080318968 Chemical Compounds
12/25/2008US20080318967 Hair Growth Promoting Agents
12/25/2008US20080318966 Sinomenine Derivatives and Preparation and Uses Thereof
12/25/2008US20080318965 Derivatives of Alpha2-Adrenergic Receptor Agonist
12/25/2008US20080318964 Deuterium-enriched eszopiclone
12/25/2008US20080318963 1-[6,7-Substituted Alkoxyquinoxalinyl) Aminocarbonyl]-4-(Hetero) Arylpiperazine Derivatives
12/25/2008US20080318961 Drugs comprising chymase inhibitors and ACE inhibitors as effective ingredients
12/25/2008US20080318960 PAR2-modulating compounds and their use
12/25/2008US20080318959 using 3-amino-5-ethyl-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide
12/25/2008US20080318958 New utilities of tricyclic compounds
12/25/2008US20080318957 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
12/25/2008US20080318956 Inflammatory cytokine release inhibitor
12/25/2008US20080318955 4-[5-(1,1,2-Trimethyl-1,1a,5,5a-tetrahydro-3-thia-cyclopropa[a]pentalen-4-yl)-[1,2,4]oxadiazol-3-yl]-phenol; G protein-coupled receptor S1P1/EDG1 (endothelial differentiation gene); new immunosuppressant; side effect reduction; transplant rejection; autoimmune diseases; antiinflammatory agents
12/25/2008US20080318954 Compounds
12/25/2008US20080318953 such as (2,4-Dimethyl-6-morpholin-4-yl-pyridin-3-yl)-carbamic acid benzyl ester, used as potassium channel modulators for the treatment of nervous system disorders; epilepsy; anxiety disorders; neuropathic pain; headaches; neurodegenerative disorders
12/25/2008US20080318952 Diaryl-substituted tetrahydroisoquinolines as histamine h3 receptor and serotonin transporter modulators
12/25/2008US20080318951 Dual-acting benzoimidazole antihypertensive agents
12/25/2008US20080318950 Quinazoline Derivatives as a Multiplex Inhibitor and Method For the Preparation Thereof
12/25/2008US20080318949 Pyrazolopyrimidinone Derivatives, Their Preparation And Their Use
12/25/2008US20080318948 activators of glucokinase activity such as (R)-3-Cyclopentyl-N-isoquinolin-1-yl-2-[4-(4-methyl-piperazine-1-sulfonyl)-phenyl]-propionamide, used for the prevention and the treatment of diabetes, non-insulin dependent diabetes and obesity
12/25/2008US20080318947 Inhibitors of Akt Activity
12/25/2008US20080318946 Di-amino-substituted heterocyclic compounds and methods of use
12/25/2008US20080318945 Novel Compounds
12/25/2008US20080318944 N-aroyl cyclic amine derivatives as orexin receptor antagonists
12/25/2008US20080318943 Compounds and Uses Thereof - 848
12/25/2008US20080318942 Fredericamycin Derivatives
12/25/2008US20080318941 4' substituted compounds having 5-ht6 receptor affinity
12/25/2008US20080318940 Quinazolinone Derivatives as Vanilloid Antagonists
12/25/2008US20080318939 Methods for treating ophthalmic disorders
12/25/2008US20080318938 Methods for treating aberrant cell proliferation disorders
12/25/2008US20080318937 Tricyclic delta-opioid modulators
12/25/2008US20080318936 Substituted 5-Phenyl-3,6-Dihydro-2-Oxo-6H-1,3,4-Thiadiazines
12/25/2008US20080318935 Substituted imidazoheterocycles
12/25/2008US20080318934 Diazepinoes
12/25/2008US20080318933 5-Sulfonyl-1-Piperidinyl Substituted Indole Derivatives as 5-Ht6 Receptor Antagonists for the Treatment of Cns Disorders
12/25/2008US20080318932 Sodium Channel Blocker Compositions and the Use Thereof
12/25/2008US20080318931 Treatment of Disorders and Diseases of the Colon
12/25/2008US20080318930 Sulfonyl Compound as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
12/25/2008US20080318929 Pyrimidine Derivatives Useful as Inhibitors of Pkc-Theta
12/25/2008US20080318928 Bengamides with a substituted caprolactam cycle, method for the preparation thereof, compositions containing them and use thereof
12/25/2008US20080318927 Substituted monocyclic CGRP receptor antagonists
12/25/2008US20080318926 Methods of Treating Mood Disorders Using Pyridyloxymethyl and Benzisoxazole Azabicyclic Derivatives
12/25/2008US20080318925 Compounds and Uses Thereof - 849
12/25/2008US20080318924 Phenoxypyridine derivative salts and crystals thereof, and process for preparing the same
12/25/2008US20080318923 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle
12/25/2008US20080318922 Bicyclic Pyrrole Derivatives
12/25/2008US20080318921 5R,6Z)-6-(Imidazo[2,1-b][1,3]benzothiazol-2-ylmethylene)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; beta -Lactamases hydrolyze beta -lactam antibiotics and as such serve as the primary cause of bacterial resistance
12/25/2008US20080318920 Deuterium-enriched ezetimibe
12/25/2008US20080318919 Cefquinome Compositions and Methods of Their Use
12/25/2008US20080318918 Methods for Treatment and Prevention of Otitis Media Using Nonionic Surfactants to Facilitate Transmembrane Drug Delivery into the Middle Ear
12/25/2008US20080318917 Polyethylene glycolated superoxide dismutase mimetics
12/25/2008US20080318916 Novel alpha glucosidase inhibitors from lichens
12/25/2008US20080318915 Deuterium-enriched fluticasone propionate
12/25/2008US20080318914 Treating a traumatic brain injury by administering progesterone; dosing regime is constant or two-level, e.g., administering a higher hourly dose followed by a second time period during which a lower hourly dose is administered
12/25/2008US20080318913 Combination of Methylxanthine Compounds and Steroids to Treat Chronic Respiratory Diseases
12/25/2008US20080318912 Medicaments for Treating Chronic Respiratory Disease
12/25/2008US20080318911 20-Cyclopropyl, 26,27-Alkyl/Haloalkyl Vitamin D3 Compounds and Methods of Use Thereof
12/25/2008US20080318910 Controlled-Release Oral Dosage Form
12/25/2008US20080318909 Use Of Linoleic Compounds Against Heart Failure
12/25/2008US20080318908 Use of gaba and gabab agonists
12/25/2008US20080318907 Nitroxide Free Radical Synergized Antineoplastic Agents
12/25/2008US20080318906 Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
12/25/2008US20080318905 Prodrugs and methods of making and using the same
12/25/2008US20080318904 Deuterium-enriched tenofovir
12/25/2008US20080318903 Methods for treating cancer
12/25/2008US20080318902 Triheterocyclic compounds and compositions thereof
12/25/2008US20080318901 enhancing wound repair; treating reperfusion type injury; lyso-lipid phosphate phosphatase inhibitor; phosphoric acid mono-[3-(4-phenyloxy-pyrimidine)-2-octadec-9-enoylamino-propyl] ester or salt
12/25/2008US20080318899 Pyridazine Compounds, Compositions and Methods
12/25/2008US20080318898 Inclusion complexes of butylphthalide with cyclodextrin or its derivatives, a process for their preparation and the use thereof
12/25/2008US20080318897 Composition Containing Swelling Agent Composed of Swellable Water-Soluble Polysaccharide, and Food, Anti-Obesity Agent and Constipation Alleviator Each Containing the Composition
12/25/2008US20080318896 Useful in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing; enhancing silencing of a target mRNA
12/25/2008US20080318895 Intranasal delivery of nucleic acid molecules
12/25/2008US20080318894 Rna antagonist compounds for the modulation of her3
12/25/2008US20080318893 Blockade of Calcium Channels
12/25/2008US20080318892 Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of nad
12/25/2008US20080318891 Antisense oligonucleotides against thymidylate synthase
12/25/2008US20080318890 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
12/25/2008US20080318889 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
12/25/2008US20080318888 Antiproliferative activity of g-rich oligonucleotides and method of using same to bind to nucleolin
12/25/2008US20080318887 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
12/25/2008US20080318886 Methods of Increasing Cancer Sensitivity to Chemotherapeutic Agents Using Chimeric ISF35
12/25/2008US20080318885 Method for Modulating Responsiveness to Steroids
12/25/2008US20080318884 Methods for Altering Gene Expression and Methods of Treatment Utilizing Same
12/25/2008US20080318883 Anti-aging supplement
12/25/2008US20080318882 Method of Delivery of Nucleic Acids to Peripheral Neurons
12/25/2008US20080318880 Neoadjuvant treatment of Breast Cancer
12/25/2008US20080318878 Antibacterial Agents
12/25/2008US20080318877 Purifications of pomegranate ellagitannins and their uses thereof
12/25/2008US20080318876 Use of Ginsenosides in the Treatment of Aids
1 ... 2933 2934 2935 2936 2937 2938 2939 2940 2941 2942 2943 2944 2945 2946 2947 2948 2949 2950 2951 2952 2953 ... 7860